InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Hannah Valantine, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 17 open-market SEC Form 4 transactions: 2 purchases worth $50K and 15 sales worth $6.2M, reported from Dec 28, 21 to Jul 16, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | CDNACareDx, Inc. | SELL | 28.7K | $36.55 | $1.0M |
| Jun 23, 26 | BBIOBridgeBio Pharma, Inc. | SELL | 2.2K | $68.57 | $151K |
| Jun 22, 26 | BBIOBridgeBio Pharma, Inc. | SELL | 2.8K | $68.00 | $191K |
| Jun 15, 26 | CDNACareDx, Inc. | SELL | 12.1K | $23.11 | $280K |
| Mar 10, 26 | BBIOBridgeBio Pharma, Inc. | SELL | 8.7K | $72.00 | $624K |
| Feb 27, 26 | BBIOBridgeBio Pharma, Inc. | SELL | 14.6K | $67.84 | $978K |
| Nov 12, 25 | BBIOBridgeBio Pharma, Inc. | SELL | 25.5K | $66.07 | $1.7M |
| Jun 26, 25 | BBIOBridgeBio Pharma, Inc. | SELL | 1.9K | $44.13 | $83K |
| Jun 18, 25 | CDNACareDx, Inc. | SELL | 10.6K | $19.16 | $203K |
| Jun 10, 25 | BBIOBridgeBio Pharma, Inc. | SELL | 4.3K | $40.00 | $172K |
| Mar 6, 25 | BBIOBridgeBio Pharma, Inc. | SELL | 12.9K | $32.58 | $419K |
| Feb 15, 24 | BBIOBridgeBio Pharma, Inc. | SELL | 2.9K | $37.75 | $110K |
| Jan 16, 24 | BBIOBridgeBio Pharma, Inc. | SELL | 2.9K | $37.97 | $111K |
| Dec 15, 23 | BBIOBridgeBio Pharma, Inc. | SELL | 2.9K | $36.12 | $105K |
| Nov 15, 23 | BBIOBridgeBio Pharma, Inc. | SELL | 2.9K | $30.00 | $87K |
| Dec 29, 21 | BBIOBridgeBio Pharma, Inc. | BUY | 1.8K | $14.24 | $25K |
| Dec 28, 21 | BBIOBridgeBio Pharma, Inc. | BUY | 1.9K | $13.18 | $25K |